摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 6-oxohept-2-enoate | 120113-89-5

中文名称
——
中文别名
——
英文名称
ethyl 6-oxohept-2-enoate
英文别名
ethyl (E)-6-oxohept-2-enoate
ethyl 6-oxohept-2-enoate化学式
CAS
120113-89-5
化学式
C9H14O3
mdl
——
分子量
170.208
InChiKey
QRMVLKSYNCXYKV-FNORWQNLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    105-108 °C(Press: 3 Torr)
  • 密度:
    0.993±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Rh(I)-catalyzed conjugate addition of alkenylzirconocene chloride: stereoselective formation of carbocycles through cascade reaction
    作者:Yuji Hanzawa、Yoshitaka Takebe、Akio Saito、Akito Kakuuchi、Haruhiko Fukaya
    DOI:10.1016/j.tetlet.2007.07.056
    日期:2007.9
    Stereoselective formation of carbocycles was carried out through [RhCl(cod)]2-catalyzed reactions of alkenylzirconocene chloride to ω-carbonyl-α,β-ene carbonyls (ketone, ester, and amide) or to bis-enone derivatives. The Rh(I)-catalyzed reaction of alkenylzirconocene chloride with ω-carbonyl-α,β-enoyl amide, which is derived from Oppolzer’s sultam, showed high diastereoselectivity to yield an carbocycle (95%
    通过[RhCl(cod)] 2催化的烯基化物与ω-羰基-α,β-烯羰基(酮,酯和酰胺)或双烯酮衍生物的立体选择形成碳环。Oppolzer's sultam衍生的链烯基化物与ω-羰基-α,β-烯丙基酰胺的Rh(I)催化反应显示出高非对映选择性,可产生碳环(95%收率,> 95%de)。
  • 1,4-Dihydropyridines with paf-antagonistic activity
    申请人:ALTER, S.A.
    公开号:EP0531598A1
    公开(公告)日:1993-03-17
    4-alkyl-1,4-dihydropyridines with activity antagonistic of the PAF-"aceter" of formula (I) are described, in which R is a saturated alkyl chain C1-2; R' is a saturated or unsaturated C1-16 lineal, branched or cyclic chain that can be interrupted by an oxygen atom and can also represent a 2-(N-morpholine) ethyl group; n is 2 or 3; X is oxygen, sulphur or SO2; Ar represents an aromatic ring that cannot be phenyl when X=S and n=2. The compounds (I) can be prepared (a) by reaction of (II) with (III) and with (IV); or (b) by reacting (V) with (VI) and (IV); or (c) by reaction of (VII) with (VI). In these formulas the different radicals have the meaning given above. Compounds of formula (I) are used for the treatment of pathologic states and disorders in which the PAF-"aceter" participates, being used, for example, in treatment of inflammatory processes, psoriasis, glomerulitis, transplant rejection, acute and chronic bronchitis, bronchial asthma, states of shock and allergies Likewise it is used for the treatment of pathologic states and disorders in which it is necessary to stimulate the cellular immunity such as in immunodeficient syndromes and other situations in which the defense capacity is reduced.
    描述了具有拮抗 PAF-"aceter "活性的式(I)的 4-烷基-1,4-二氢吡啶类化合物,其中 R 是饱和烷基链 C1-2;R'是饱和或不饱和 C1-16 直链、支链或环链,可被氧原子打断,也可代表 2-(N-吗啉)乙基;n 是 2 或 3;X 是氧、或 SO2;Ar 代表芳香环,当 X=S 和 n=2 时不能是苯基。化合物(I)可以(a)通过(II)与(III)和(IV)反应制备;或(b)通过(V)与(VI)和(IV)反应制备;或(c)通过(VII)与(VI)反应制备。在这些式子中,不同基团的含义如上。 式(I)化合物可用于治疗 PAF-"aceter "参与的病理状态和疾病,例如用于治疗炎症过程、屑病、肾小球炎、移植排斥反应、急慢性支气管炎、支气管哮喘、休克状态和过敏。
  • US5298619A
    申请人:——
    公开号:US5298619A
    公开(公告)日:1994-03-29
查看更多